Susquehanna International Group, LLP Staar Surgical CO Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$29.97 - $47.42 $653,346 - $1.03 Million	21,800 Added 48.44%	66,800 $2.48 Million
Q2 2024 Aug 15, 2024	SELL	$38.07 - $52.25 $609,120 - $836,000	-16,000 Reduced 26.23%	45,000 $2.14 Million
Q1 2024 May 07, 2024	SELL	$27.67 - $39.61 $1.62 Million - $2.32 Million	-58,600 Reduced 49.0%	61,000 $2.34 Million
Q4 2023 Feb 14, 2024	SELL	$30.6 - $43.78 $2.77 Million - $3.96 Million	-90,400 Reduced 43.05%	119,600 $3.73 Million
Q3 2023 Nov 14, 2023	BUY	$39.39 - $58.12 $4.28 Million - $6.32 Million	108,700 Added 107.31%	210,000 $8.44 Million
Q2 2023 Aug 11, 2023	BUY	$50.45 - $72.82 $3.12 Million - $4.51 Million	61,900 Added 157.11%	101,300 $5.33 Million
Q1 2023 May 16, 2023	SELL	$51.25 - $79.34 $948,125 - $1.47 Million	-18,500 Reduced 31.95%	39,400 $2.52 Million
Q4 2022 Feb 14, 2023	SELL	$46.82 - $76.2 $1.24 Million - $2.02 Million	-26,500 Reduced 31.4%	57,900 $2.81 Million
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $2.14 Million - $3.39 Million	30,400 Added 56.3%	84,400 $5.95 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.